as on November 11, 2025 at 4:01 pm IST
Day's Low
Day's High
0.51%
Downside
0.77%
Upside
52 Week's Low
52 Week's High
8.76%
Downside
55.20%
Upside
as on November 11, 2025 at 4:01 pm IST
Market Cap
₹1,420.57 Cr
Return on Equity (ROE)
18.58
PE Ratio (TTM)
0Return on capital employed (ROCE)
22.82
Beta (LTM)
1.83
P/B Ratio
5.99
Dividend Yield
0PEG Ratio
0Quarterly Earnings Growth YOY
9.69
EPS (TTM)
0Sector
Pharmaceuticals
Book Value
0Technical Analysis
Bearish
View Technical Analysis
Compare market cap, revenue, PE, and other key metrics of Jagsonpal Pharmaceuticals Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 1,420.57 | 244.14% | 0.00 | 55 | 268 | |
| NA | 230.48 | 110.24% | 0.00 | -10 | 109 | |
| NA | 1,045.75 | 26.34% | 0.50 | 82 | 623 | |
| NA | 122.49 | 82.97% | 0.00 | NA | 3 | |
| BUY | 4,279.42 | 686.07% | 0.56 | 95 | 921 |
Search interest for Jagsonpal Pharmaceuticals Ltd Stock has increased by 30% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:30% versus previous 30 day period
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Jagsonpal Pharmaceuticals Ltd.
Jagsonpal Pharmaceuticals Ltd’s net profit jumped 9.69% since last year same period to ₹12.57Cr in the Q2 2025-2026. On a quarterly growth basis, Jagsonpal Pharmaceuticals Ltd has generated 16.39% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Jagsonpal Pharmaceuticals Ltd has declared dividend of ₹2.50 per share on 06 May 2025 - translating a dividend yield of 3.52%.
Read More about DividendsCheck stock indices that include Jagsonpal Pharmaceuticals Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
![]()
Retail Investor have increased holdings from 30.12% to 30.25% in Sep 2025 quarter
Price Dip
![]()
In the last 3 months, JAGSNPHARM stock has moved down by -14.7%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 2.18% to 2.12% in Sep 2025 quarter
Promoter Holding Down
![]()
Promoters have decreased holdings from 67.65% to 67.54% in Sep 2025 quarter
| Organisation | Jagsonpal Pharmaceuticals Ltd |
| Headquarters | Gurgaon |
| Industry | Pharmaceuticals |
| CEO | Harsha Raghavan |
| E-voting on shares | Click here to vote |
Jagsonpal Pharmaceuticals Ltd share price today stands at ₹211.37 as on at the close of the market. Jagsonpal Pharmaceuticals Ltd share today touched a day high of ₹213 and a low of ₹210.3.
Jagsonpal Pharmaceuticals Ltd touched a 52 week high of ₹328.04 and a 52 week low of ₹192.85. Jagsonpal Pharmaceuticals Ltd share price today i.e. is closed at ₹211.37, which is -35.57% down from its 52 week high and 9.60% up from its 52 week low.
Jagsonpal Pharmaceuticals Ltd market capitalisation is ₹1,420.57 Cr as on .
To buy Jagsonpal Pharmaceuticals Ltd shares, you need to follow these steps:
Jagsonpal Pharmaceuticals Ltd trading volume is 45.07K as on . This means that 45.07K shares of Jagsonpal Pharmaceuticals Ltd were bought and sold on the stock market during today's trading session.